Page last updated: 2024-12-11
n-(3-(dimethylamino)propyl)oleamide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
N-(3-(dimethylamino)propyl)oleamide: RN given refers to (Z)-isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 6436063 |
| SCHEMBL ID | 4622859 |
| MeSH ID | M0129876 |
Synonyms (39)
| Synonym |
|---|
| 9-octadecenamide, n-[3-(dimethylamino)propyl]-, (9z)- |
| lexamine o 13 |
| oleamide, n-[3-(dimethylamino)propyl]- |
| tegamine o 13 |
| tegamine 0-13 |
| oleamidopropyl dimethylamine |
| oleamide, n-[3-(dimethylamino)propyl]-) |
| oleic acid-n,n-dimethyltrimethylenediamine condensate |
| 109-28-4 |
| n-[3-(dimethylamino)propyl]oleamide |
| nsc258347 |
| nsc-258347 |
| (z)-n-[3-(dimethylamino)propyl]octadec-9-enamide |
| nsc 258347 |
| 9-octadecenamide, n-(3-(dimethylamino)propyl)- |
| 9-octadecenamide, n-(3-(dimethylamino)propyl)-, (z)- |
| unii-79k39ju7rn |
| einecs 203-661-5 |
| n-(3-(dimethylamino)propyl)-9-octadecenamide |
| 9-octadecenamide, n-(3-(dimethylamino)propyl)-, (9z)- |
| (3-(oleoylamido)propyl)dimethylamine |
| dimethylaminopropyl oleamide |
| oleamide, n-(3-(dimethylamino)propyl)- |
| 79k39ju7rn , |
| n-(3-(dimethylamino)propyl)oleamide |
| oleamidopropyl dimethylamine [inci] |
| schercodine o |
| oleic acid 3-(n,n-dimethylamino)propylamide |
| schercodine o amido-amine |
| unizeen oa |
| mackine 501 |
| SCHEMBL4622859 |
| oleoylaminopropyl-n,n-dimethylamine |
| UCWYGNTYSWIDSW-QXMHVHEDSA-N |
| 9-octadecenamide,n-[3-(dimethylamino)propyl]-, (9z)- |
| DTXSID10873803 |
| n-3-oleylamidopropyl dimethylamine |
| Q27266762 |
| 9-octadecenamide,n-[3-(dimethylamino)propyl]-,(9z)- |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.12
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.12) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 3 (33.33%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (66.67%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||